• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

HISTORIC SETTLEMENT WITH MERCK/IDENIX AND GILEAD ANNOUNCED!!!













That's why we slowed down the development of PSI-6130. We knew that things were really over.
signed Roche

We even had Pat tell us a few things that were very helpful, but DO NOT TELL ANYONE I TOLD YOU THAT!!!

YOU IDENIX PEOPLE ARE FREAKS!!! Don't you get it. We own the market. You cant even get a drug to market. Go away you bother me.